RI
RTW Investments Portfolio holdings
AUM
$7.02B
This Quarter Return
+25.3%
1 Year Return
+28.16%
3 Year Return
+245.48%
5 Year Return
+425.65%
10 Year Return
+5,642.23%
AUM
$474M
AUM Growth
+$474M
(+25%)
Cap. Flow
+$50.9M
Cap. Flow
% of AUM
10.74%
Top 10 Holdings %
Top 10 Hldgs %
76.63%
Holding
34
New
6
Increased
17
Reduced
4
Closed
6
Top Buys
| 1 |
PTC Therapeutics
PTCT
|
$36.6M |
| 2 |
Arbutus Biopharma
ABUS
|
$13.5M |
| 3 |
Bristol-Myers Squibb
BMY
|
$11.4M |
| 4 |
ACHN
Achillion Pharmaceuticals, Inc.
ACHN
|
$7.3M |
| 5 |
Omeros
OMER
|
$4.73M |
Top Sells
| 1 |
MDCO
Medicines Co
MDCO
|
$28M |
| 2 |
Incyte
INCY
|
$11M |
| 3 |
Alnylam Pharmaceuticals
ALNY
|
$4.14M |
| 4 |
IVTY
Invuity, Inc
IVTY
|
$3.24M |
| 5 |
AVXS
AveXis, Inc. Common Stock
AVXS
|
$2.98M |
Sector Composition
| 1 | Healthcare | 97.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Alnylam Pharmaceuticals
ALNY
$58.5B
| $83M | 17.5% | 1,040,607 -51,909 | -5% | -$4.14M |
|
|
2
PTC Therapeutics
PTCT
$3.92B
| $60.6M | 12.77% | 3,304,214 +1,998,571 | +153% | +$36.6M |
|
|
AVXS
3
DELISTED
AveXis, Inc. Common Stock
AVXS
| $48.2M | 10.17% | 587,117 -36,213 | -6% | -$2.98M |
|
|
4
Bristol-Myers Squibb
BMY
$96B
| $43.2M | 9.1% | 774,675 +203,983 | +36% | +$11.4M |
|
|
LJPC
5
DELISTED
La Jolla Pharmaceutical Company
LJPC
| $33M | 6.95% | 1,107,379 +78,450 | +8% | +$2.34M |
|
6
Regenxbio
RGNX
$451M
| $25.1M | 5.3% | 1,272,770 +56,265 | +5% | +$1.11M |
|
|
7
Arbutus Biopharma
ABUS
$711M
| $18.8M | 3.95% | 5,209,823 +3,763,236 | +260% | +$13.5M |
|
8
BioCryst Pharmaceuticals
BCRX
$1.74B
| $18.5M | 3.91% | 3,333,958 -124,162 | -4% | -$690K |
|
|
AGEN
9
Agenus
AGEN
$133M
| $16.7M | 3.53% | 4,277,456 +31,574 | +0.7% | +$123K |
|
10
Atara Biotherapeutics
ATRA
$84.6M
| $16.4M | 3.46% | 1,172,744 +264,011 | +29% | +$3.7M |
|
|
OXFD
11
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
| $14.2M | 3% | 846,917 +234,014 | +38% | +$3.94M |
|
|
CORI
12
DELISTED
Corium International, Inc.
CORI
| $12.2M | 2.57% | 1,632,001 +183,010 | +13% | +$1.37M |
|
|
BLUE
13
DELISTED
bluebird bio
BLUE
| $11M | 2.31% | 104,383 +766 | +0.7% | +$80.5K |
|
14
Tactile Systems Technology
TCMD
$297M
| $10.6M | 2.24% | 372,302 +84,426 | +29% | +$2.41M |
|
15
OraSure Technologies
OSUR
$242M
| $10.2M | 2.14% | 588,256 +22,026 | +4% | +$380K |
|
16
Masimo
MASI
$7.59B
| $9.2M | 1.94% | 100,900 +20,000 | +25% | +$1.82M |
|
|
VIVE
17
DELISTED
VIVEVE MED INC
VIVE
| $8.9M | 1.88% | 1,239,443 +93,707 | +8% | +$673K |
|
|
ACHN
18
DELISTED
Achillion Pharmaceuticals, Inc.
ACHN
| $7.3M | 1.54% | +1,590,454 | New | +$7.3M |
|
|
DRNA
19
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $6.59M | 1.39% | 2,078,991 +16,000 | +0.8% | +$50.7K |
|
|
VRAY
20
DELISTED
ViewRay, Inc.
VRAY
| $4.95M | 1.04% | 764,335 +248,723 | +48% | +$1.61M |
|
|
21
Omeros
OMER
$283M
| $4.73M | 1% | +237,453 | New | +$4.73M |
|
|
FSTX
22
DELISTED
F-star Therapeutics, Inc. Common Stock
FSTX
| $3.39M | 0.71% | +250,000 | New | +$3.39M |
|
23
Universal Health Services
UHS
$11.6B
| $3.15M | 0.66% | +25,800 | New | +$3.15M |
|
24
Insulet
PODD
$23.9B
| $2.98M | 0.63% | +58,000 | New | +$2.98M |
|
|
GBT
25
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $721K | 0.15% | 26,377 +194 | +0.7% | +$5.3K |
|